Vaccines
Saunders (Publisher)
2nd Edition
Published in August 1994
Book
Hardback
1016 pages
978-0-7216-6584-9 (ISBN)
Article exhausted; check for reprint
Description
As the debate over health care reform continues, this reference covers everything about vaccines in current, public use - the diseases being guarded against, their epidemiology, the composition of the vaccines, their immunogenicity, side effects, and the impact on public health. It gives both the theoretical and practical information needed to use the vaccines most effectively. Features new to this edition include: new chapters on Japanese B. encephalitis, tick-borne encephalitis, and anthrax; extensive revisions made to chapters on mumps, hepatitis B, BCG, HIV, and public health considerations; new authors who have contributed to discussions on the adenovirus vaccine, meningococcal vaccines, and cytomegalovirus vaccines; coverage of recent advances - including vaccines not yet licensed, alerting readers to new developments in inoculating against hepatitis A, varicella and AIDS; and a practical approach, looking at non-clinical considerations of effective vaccination, such as legal issues and the impact of vaccines on public health.
As the debate over health care reform continues, this reference covers everything about vaccines in current, public use - the diseases being guarded against, their epidemiology, the composition of the vaccines, their immunogenicity, side effects, and the impact on public health. It gives both the theoretical and practical information needed to use the vaccines most effectively. Features new to this edition include: new chapters on Japanese B. encephalitis, tick-borne encephalitis, and anthrax; extensive revisions made to chapters on mumps, hepatitis B, BCG, HIV, and public health considerations; new authors who have contributed to discussions on the adenovirus vaccine, meningococcal vaccines, and cytomegalovirus vaccines; coverage of recent advances - including vaccines not yet licensed, alerting readers to new developments in inoculating against hepatitis A, varicella and AIDS; and a practical approach, looking at non-clinical considerations of effective vaccination, such as legal issues and the impact of vaccines on public health.
As the debate over health care reform continues, this reference covers everything about vaccines in current, public use - the diseases being guarded against, their epidemiology, the composition of the vaccines, their immunogenicity, side effects, and the impact on public health. It gives both the theoretical and practical information needed to use the vaccines most effectively. Features new to this edition include: new chapters on Japanese B. encephalitis, tick-borne encephalitis, and anthrax; extensive revisions made to chapters on mumps, hepatitis B, BCG, HIV, and public health considerations; new authors who have contributed to discussions on the adenovirus vaccine, meningococcal vaccines, and cytomegalovirus vaccines; coverage of recent advances - including vaccines not yet licensed, alerting readers to new developments in inoculating against hepatitis A, varicella and AIDS; and a practical approach, looking at non-clinical considerations of effective vaccination, such as legal issues and the impact of vaccines on public health.
More details
Edition
2nd Revised edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
College/higher education
Professional and scholarly
Edition type
Revised edition
Illustrations
112 illustrations, appendices
Dimensions
Height: 260 mm
Width: 184 mm
Weight
2039 gr
ISBN-13
978-0-7216-6584-9 (9780721665849)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Stanley A. Plotkin | Edward A. Mortimer | Walter A. Orenstein
Vaccines
Book
01/1999
3rd Edition
Saunders
€222.84
Article exhausted; check for reprint
Content
A short history of vaccination; small pox and vaccinia; diphtheria toxoid; tetanus; pertussis vaccine; polio - historical; live attenuated poliovaccines; noninfectious poliovirus vaccine; measles vaccine; mumps vaccine; rubella vaccine; haemophilus influenzae vaccines; varicella vaccine; hepatitis B vaccine; bacille calmette-guerin (BCG) vaccine; adenovirus vaccine; meningococcal vaccines; pneumococcal vaccine; inactivated influenza vaccines; hepatitis A vaccine; typhoid fever vaccines; cholera; rabies vaccine; Japanese B encephalitis; tick-borne encephalitis; plague; anthrax; yellow fever vaccine; live influenza virus vaccine; cytomegalovirus vaccines; rotavirus vaccines; human immunodeficiency virus; new technologies for making vaccines; regulation and testing of vaccines; public health considerations; American law and preventive vaccination programs.